Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
52.70
+0.20 (0.38%)
Aug 17, 2026, 11:03 AM CET
Recordati Industria Chimica e Farmaceutica Employees
As of December 31, 2025, Recordati Industria Chimica e Farmaceutica had 4,693 total employees, including 4,614 full-time and 79 part-time employees. The number of employees increased by 110 or 2.40% compared to the previous year.
Employees
4,693
Change (1Y)
110
Growth (1Y)
2.40%
Revenue / Employee
€581,289
Profits / Employee
€106,828
Market Cap
10.75B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4,693 | 110 | 2.40% | 4,614 | 79 |
| Dec 31, 2024 | 4,583 | 128 | 2.87% | 4,495 | 88 |
| Dec 31, 2023 | 4,455 | 86 | 1.97% | 4,455 | 0 |
| Dec 31, 2022 | 4,369 | 66 | 1.53% | 4,369 | 0 |
| Dec 31, 2021 | 4,303 | -183 | -4.08% | 4,303 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amplifon | 15,078 |
| GPI S.p.A. | 7,834 |
| Safilo Group | 3,400 |
| DiaSorin | 3,272 |
| Garofalo Health Care | 2,714 |
| EL.En. | 1,428 |
| Svas Biosana | 348 |
| Talea Group | 240 |
Recordati Industria Chimica e Farmaceutica News
- 18 days ago - Recordati Industria Chimica e Farmaceutica Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - Recordati Industria Chimica e Farmaceutica Earnings release: Q2 2026 - Filings
- 18 days ago - Recordati Industria Chimica e Farmaceutica Slides: Q2 2026 - Filings
- 18 days ago - Recordati Industria Chimica e Farmaceutica Quarterly report: Q2 2026 - Filings
- 19 days ago - Recordati Earnings Up In H1; Maintains FY26 Outlook - Nasdaq
- 19 days ago - Recordati first-half core profit rises 8.8% on rare diseases - Reuters
- 4 weeks ago - Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent - Reuters
- 3 months ago - CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private - WSJ